• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:王诗蒙,王帅,李天娇,孟宪生,包永睿,赵琳.基于谱效关系的核桃楸皮治疗肝癌药效物质基础研究[J].药学研究,2023,42(1):13-17,27[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2686次   下载 2574次 本文二维码信息
码上扫一扫!
基于谱效关系的核桃楸皮治疗肝癌药效物质基础研究
王诗蒙1,王帅1,2,3,李天娇1,2,3,孟宪生1,2,3,包永睿1,2,3,赵琳1
字体:加大+|默认|缩小-
(1.辽宁中医药大学药学院,辽宁 大连 116600;2.辽宁省中药多维分析专业技术创新中心,辽宁 大连 116600;3.辽宁省现代中药研究工程实验室,辽宁 大连 116600)
摘要:
目的 基于核桃楸皮不同极性部位HPLC指纹图谱与抗肝癌作用的谱效关系,筛选出核桃楸皮治疗肝癌的药效物质,揭示其治疗肝癌的药效物质基础。方法 采用HPLC法建立核桃楸皮不同极性部位的指纹图谱;采用CCK-8法开展核桃楸皮不同极性部位治疗肝癌的体外药效学研究;采用灰色关联度分析法及偏最小二乘回归分析法,将指纹图谱共有峰峰面积与药效学数据相关联,建立核桃楸皮不同极性部位治疗肝癌体外谱效关系,筛选出其治疗肝癌的药效物质,并进行体外药效验证。结果 不同极性部位指纹图谱中共24个共有峰,其中有8个峰与药效呈正相关且VIP值大于1,确认这8种成分为核桃楸皮治疗肝癌的药效物质。经对照品比对,指认出4号峰为丁香酸、9号峰为鞣花酸、10号峰为槲皮苷、16号峰为山柰酚。结论 本研究通过建立谱效关系筛选出了核桃楸皮治疗肝癌的药效物质,揭示了核桃楸皮治疗肝癌的药效物质基础。
关键词:  核桃楸皮  指纹图谱  肝癌  谱效关系  药效物质
DOI:10.13506/j.cnki.jpr.2023.01.003
基金项目:揭榜挂帅(科技攻关专项)(No.2021JH1/10400058)
出版日期:2023-01-25
Study on the pharmacodynamic material basis of Cortex Juglans mandshurica in the treatment of liver cancer based on the spectrum-effect relationship
WANG Shimeng1,WANG Shuai1,2,3,LI Tianjiao1,2,3,MENG Xiansheng1,2,3,BAO Yongrui1,2,3,ZHAO Lin1
(1. College of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian 116600, China; 2. Liaoning Multi-dimensional analysis of Traditional Chinese Medicine Technical Innovation Center, Dalian 116600, China; 3. Liaoning Province Modern Traditional Chinese Medicine Research and Engineering Laboratory, Dalian 116600, China)
Abstract:
Objective Based on the spectrum-effect relationship between HPLC fingerprints of different polar parts of Cortex Juglans mandshurica and its anti-hepatocarcinoma effect, the pharmacodynamic substances of Cortex Juglans mandshurica for the treatment of hepatocarcinoma were screened out, and the pharmacodynamic material basis of Cortex Juglans mandshurica for the treatment of hepatocarcinoma was revealed. Methods HPLC method was used to establish the fingerprint of different polar parts of Cortex Juglans mandshurica, and CCK-8 method was used to study the pharmacodynamics of different polar parts of Cortex Juglans mandshurica on liver cancer in vitro in order to establish the in vitro spectral response relationship of different polar parts o Cortex Juglans mandshurica for the treatment of liver cancer, the common peak area of the fingerprint was correlated with the pharmacodynamic data by using gray correlation degree analysis and partial least squares regression analysis, the pharmacodynamic substances for the treatment of liver cancer were screened out and their pharmacodynamic effects were verified in vitro. Results There were 24 common peaks in the fingerprint of different polar parts, and 8 of them showed positive correlation with the drug effect and the VIP value was greater than 1. It was confirmed that these 8 components were the drug effective substances of Cortex Juglans mandshurica for treating liver cancer. The results showed that peak No. 4 was syringic acid, peak No. 9 was ellagic acid, peak No. 10 was quercetin and peak No. 16 was kaempferol. Conclusion In this study, the pharmacodynamic substances of Cortex Juglans mandshurica in the treatment of liver cancer were screened by establishing the spectrum-effect relationship, and the pharmacodynamic material basis of Cortex Juglans mandshurica in the treatment of liver cancer was revealed.
Key words:  Cortex Juglans mandshurica  Fingerprint  Liver cancer  Spectrum-effect relationship  Pharmacodynamic substances
今日访问量:2655    总访问量:55339171
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司